Results 11 to 20 of about 1,855 (148)

Citologia de impressão na avaliação de tumores da superfície ocular: artigo de revisão [PDF]

open access: yes, 2015
Impression cytology (IC) has been widely used as a method for evaluating the ocular surface and superficial cells layers in the diagnosis and follow-up after treatment of several ocular surface tumors of both epithelial and melanocytic origin ...
Araujo de Almeida, Simone Ribeiro   +4 more
core   +11 more sources

Topical fl uorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial [PDF]

open access: yes, 2016
Background Ocular surface squamous neoplasia (OSSN) is an aggressive eye tumour particularly aff ecting people with HIV in Africa. Primary treatment is surgical excision; however, tumour recurrence is common. We assessed the eff ect of fl uorouracil 1%
A Weiss, Helen   +12 more
core   +9 more sources

Paraneoplastic pemphigus: insight into the autoimmune pathogenesis, clinical features and therapy [PDF]

open access: yes, 2017
Paraneoplastic pemphigus is a rare autoimmune skin disease that is always associated with a neoplasm. Usually, oral, skin, and mucosal lesions are the earliest manifestations shown by paraneoplastic pemphigus patients.
Andrea Ciofalo   +21 more
core   +2 more sources

Negative hybrid capture in a single intraepithelial corneal dysplasia [PDF]

open access: yes, 2010
As displasias intraepiteliais de córnea correspondem a lesões de baixo risco de malignidade, dentro do espectro das neoplasias intraepiteliais da superfície ocular.
BONINI FILHO, Marco Antonio   +6 more
core   +2 more sources

p16INK4A expression is frequently increased in periorbital and ocular squamous lesions [PDF]

open access: yes, 2015
Backgroundp16 expression is a well established biomarker of cervical dysplasia and carcinoma arising from high risk human papilloma virus infection. Increased p16 expression is also seen in squamous neoplasms arising at other sites, including head, neck,
Bobby S. Korn   +7 more
core   +2 more sources

Topical use of mitomycin C for the treatment of corneal-conjunctival intraepithelial neoplasia and conjunctival squamous cell carcinoma: preliminary results [PDF]

open access: yes, 2003
PURPOSE: The purpose of this study is to evaluate the safety, efficacy and recurrence after topical use of mitomycin C (MMC) for primary or recurrent corneal-conjunctival intraepithelial neoplasia (CIN) and recurrent squamous cell carcinoma (SCC ...
Ballalai, Priscilla Luppi   +5 more
core   +2 more sources

Carcinoma de glândulas sebáceas palpebral - diferentes momentos de diagnósticos, diferentes resultados cirúrgicos: relatos de casos [PDF]

open access: yes, 2011
Sebaceous carcinoma of the eyelid is a very rare slow-growing tumor and is considered an aggressive eyelid neoplasm. It can reach mortality rate of about 6%.
Cariello, Angelino Julio   +4 more
core   +3 more sources

Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region. [PDF]

open access: yes, 2017
Importance: Primary diffuse large B-cell lymphoma (DLBCL) of the ocular region is rare, and the utility of surgery and radiation therapy remains unresolved.
Ahmed, Aseef H H.   +2 more
core   +2 more sources

Pilomatrix carcinoma of the lacrimal caruncle: a case report. [PDF]

open access: yes, 2020
A 45-year-old man presented with a 3-month history of a mass located in the caruncle of his right eye. An incisional biopsy had been performed one month prior by another specialist, and the histopathology report showed basal cell carcinoma.
Acıkalin, Arbil   +4 more
core   +1 more source

Incidence of orbital, conjunctival and lacrimal gland malignant tumors in USA from Surveillance, Epidemiology and End Results, 1973-2009 [PDF]

open access: yes, 2016
AIM: To determine the types and incidence of tumors affecting the orbit, conjunctiva and lacrimal glands and to study the trend line of these tumors in the United States from 1973 to 2009.
Alfaar, Ahmad S.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy